Logo image of CHY

CALAMOS CONVERT & HIGH INC (CHY) Stock Price, Quote, News and Overview

NASDAQ:CHY - Nasdaq - US12811P1084 - Currency: USD

10.1  +0.08 (+0.8%)

After market: 10.15 +0.05 (+0.5%)

Fundamental Rating

1

Overall CHY gets a fundamental rating of 1 out of 10. We evaluated CHY against 0 industry peers in the Unkown industry. CHY has a bad profitability rating. Also its financial health evaluation is rather negative. CHY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CHY has reported negative net income.
CHY had a positive operating cash flow in the past year.
In multiple years CHY reported negative net income over the last 5 years.
Of the past 5 years CHY 4 years had a positive operating cash flow.
CHY Yearly Net Income VS EBIT VS OCF VS FCFCHY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA -0.79%
ROE -1.33%
ROIC 1.01%
ROA(3y)-2.52%
ROA(5y)3.06%
ROE(3y)-4.97%
ROE(5y)3.75%
ROIC(3y)N/A
ROIC(5y)N/A
CHY Yearly ROA, ROE, ROICCHY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

1.3 Margins

CHY's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of CHY has declined.
Industry RankSector Rank
OM 58.16%
PM (TTM) N/A
GM 58.76%
OM growth 3Y-10.43%
OM growth 5Y-6.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-6.81%
CHY Yearly Profit, Operating, Gross MarginsCHY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20K -40K -60K

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CHY has more shares outstanding
Compared to 5 years ago, CHY has more shares outstanding
Compared to 1 year ago, CHY has a worse debt to assets ratio.
CHY Yearly Shares OutstandingCHY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CHY Yearly Total Debt VS Total AssetsCHY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

CHY has an Altman-Z score of 0.84. This is a bad value and indicates that CHY is not financially healthy and even has some risk of bankruptcy.
CHY has a debt to FCF ratio of 4.49. This is a neutral value as CHY would need 4.49 years to pay back of all of its debts.
A Debt/Equity ratio of 0.67 indicates that CHY is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 4.49
Altman-Z 0.84
ROIC/WACCN/A
WACCN/A
CHY Yearly LT Debt VS Equity VS FCFCHY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 6.30 indicates that CHY has no problem at all paying its short term obligations.
CHY has a Quick Ratio of 6.30. This indicates that CHY is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 6.3
Quick Ratio 6.3
CHY Yearly Current Assets VS Current LiabilitesCHY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

CHY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.18%, which is quite impressive.
CHY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.23%.
Measured over the past years, CHY shows a very negative growth in Revenue. The Revenue has been decreasing by -16.51% on average per year.
EPS 1Y (TTM)97.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.52%
Revenue 1Y (TTM)12.23%
Revenue growth 3Y-22.67%
Revenue growth 5Y-16.51%
Sales Q2Q%-2.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHY Yearly Revenue VS EstimatesCHY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CHY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHY Price Earnings VS Forward Price EarningsCHY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 7.29
EV/EBITDA N/A
CHY Per share dataCHY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

CHY has a Yearly Dividend Yield of 12.16%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.51, CHY pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.16%

5.2 History

The dividend of CHY decreases each year by -0.59%.
CHY has been paying a dividend for at least 10 years, so it has a reliable track record.
CHY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-0.59%
Div Incr Years0
Div Non Decr Years4
CHY Yearly Dividends per shareCHY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CHY has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-867.69%
EPS Next 2YN/A
EPS Next 3YN/A
CHY Yearly Income VS Free CF VS DividendCHY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

More info and screens

CALAMOS CONVERT & HIGH INC

NASDAQ:CHY (4/24/2025, 8:00:00 PM)

After market: 10.15 +0.05 (+0.5%)

10.1

+0.08 (+0.8%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners16.64%
Inst Owner Change0.98%
Ins Owners0%
Ins Owner Change0%
Market Cap787.40M
Analysts0
Price TargetN/A
Short Float %0.23%
Short Ratio0.62
Dividend
Industry RankSector Rank
Dividend Yield 12.16%
Yearly Dividend1.1
Dividend Growth(5Y)-0.59%
DP-867.69%
Div Incr Years0
Div Non Decr Years4
Ex-Date04-11 2025-04-11 (0.1)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 29.51
P/FCF 7.29
P/OCF 7.29
P/B 1.09
P/tB 1.09
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.39
FCFY13.72%
OCF(TTM)1.39
OCFY13.72%
SpS0.34
BVpS9.3
TBVpS9.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.79%
ROE -1.33%
ROCE 1.28%
ROIC 1.01%
ROICexc 1.03%
ROICexgc 1.03%
OM 58.16%
PM (TTM) N/A
GM 58.76%
FCFM 404.87%
ROA(3y)-2.52%
ROA(5y)3.06%
ROE(3y)-4.97%
ROE(5y)3.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-27.01%
ROICexcg growth 5Y-21.84%
ROICexc growth 3Y-27.01%
ROICexc growth 5Y-21.84%
OM growth 3Y-10.43%
OM growth 5Y-6.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-6.81%
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 4.49
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.85
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.3
Quick Ratio 6.3
Altman-Z 0.84
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.23%
Revenue growth 3Y-22.67%
Revenue growth 5Y-16.51%
Sales Q2Q%-2.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.2%
EBIT growth 3Y-30.73%
EBIT growth 5Y-22.33%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.51%
FCF growth 3Y21.73%
FCF growth 5Y9.7%
OCF growth 1Y0.51%
OCF growth 3Y21.73%
OCF growth 5Y9.7%